Results 101 to 110 of about 1,831,704 (212)

Emerging nanomedicine for liver diseases treatment. [PDF]

J Nanobiotechnology
Zhu Y, Ge D, Wang J, Sun H, Li W, Ren H.
europepmc   +1 more source

Notch signaling in liver diseases: mechanistic insights and therapeutic implications. [PDF]

Front Cell Dev Biol
Shi Q, Lou N, Huang D, Fu L.
europepmc   +1 more source

Targeting magnesium homeostasis: a novel therapeutic strategy for liver diseases. [PDF]

Front Nutr
Ji L, Yu H, Wang R, Yan H, Yin X, Guo S, Wang R.   +6 more
europepmc   +1 more source

Matrine in Liver Diseases: Mechanistic Insights and Therapeutic Potential. [PDF]

Drug Des Devel Ther
Wen W, Xia J, Liu G, Wang C.
europepmc   +1 more source

Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases. [PDF]

J Gastroenterol Hepatol
Li Y, Li J, Dullaart RPF, Moshage H.
europepmc   +1 more source

Special Issue "Mechanistic and Prognostic Biomarkers in Liver Diseases". [PDF]

Livers
Jaeschke H, McGill MR.
europepmc   +1 more source

Rare liver diseases - Etiology, diagnosis and management: A review. [PDF]

Biomol Biomed
Long Q, Tawfeeq RD, Jiang Y, Liu H, Tan M.   +4 more
europepmc   +1 more source

Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune-mediated liver diseases. [PDF]

Front Immunol
Chen Y, Wang Z, Zeng Y, Xie X, Liu L, Qian Y.   +5 more
europepmc   +1 more source

The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology

Journal of Translational Medicine
Ki-Kwang Oh, Jung-A Eom, Kyeong Jin Lee, Goo-Hyun Kwon, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Dong Joon Kim, Ki-Tae Suk   +9 more
doaj   +1 more source

Recapitulating Liver Embryology-Lessons to Be Learned for Liver Diseases. [PDF]

J Dev Biol
Oliveira RC, Ferreira S, Gonçalves I, Martins MF.   +3 more
europepmc   +1 more source